S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

Prenetics Global (PRE) Competitors

$4.94
+0.08 (+1.65%)
(As of 05:18 PM ET)

PRE vs. FHLT, ARYD, CKPT, BYSI, AADI, IMAC, BNGO, CTSO, TARA, and FIXX

Should you be buying Prenetics Global stock or one of its competitors? The main competitors of Prenetics Global include Future Health ESG (FHLT), ARYA Sciences Acquisition Corp IV (ARYD), Checkpoint Therapeutics (CKPT), BeyondSpring (BYSI), Aadi Bioscience (AADI), IMAC (IMAC), Bionano Genomics (BNGO), Cytosorbents (CTSO), Protara Therapeutics (TARA), and Homology Medicines (FIXX). These companies are all part of the "medical" sector.

Prenetics Global vs.

Future Health ESG (NASDAQ:FHLT) and Prenetics Global (NASDAQ:PRE) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk, analyst recommendations and community ranking.

11.9% of Future Health ESG shares are owned by institutional investors. Comparatively, 39.1% of Prenetics Global shares are owned by institutional investors. 57.2% of Future Health ESG shares are owned by company insiders. Comparatively, 7.8% of Prenetics Global shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Prenetics Global has a consensus target price of $60.00, suggesting a potential upside of 1,122.00%. Given Future Health ESG's higher probable upside, analysts clearly believe Prenetics Global is more favorable than Future Health ESG.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Future Health ESG
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Prenetics Global
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Prenetics Global received 4 more outperform votes than Future Health ESG when rated by MarketBeat users.

CompanyUnderperformOutperform
Future Health ESGN/AN/A
Prenetics GlobalOutperform Votes
4
80.00%
Underperform Votes
1
20.00%

Future Health ESG has a net margin of 0.00% compared to Future Health ESG's net margin of -55.31%. Future Health ESG's return on equity of -3.89% beat Prenetics Global's return on equity.

Company Net Margins Return on Equity Return on Assets
Future Health ESGN/A -9.79% 5.52%
Prenetics Global -55.31%-3.89%-3.10%

Future Health ESG has a beta of -0.01, suggesting that its stock price is 101% less volatile than the S&P 500. Comparatively, Prenetics Global has a beta of -0.11, suggesting that its stock price is 111% less volatile than the S&P 500.

In the previous week, Future Health ESG and Future Health ESG both had 2 articles in the media. Prenetics Global's average media sentiment score of 1.89 beat Future Health ESG's score of 0.30 indicating that Future Health ESG is being referred to more favorably in the media.

Company Overall Sentiment
Future Health ESG Very Positive
Prenetics Global Neutral

Future Health ESG has higher earnings, but lower revenue than Prenetics Global.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Future Health ESGN/AN/A$60KN/AN/A
Prenetics Global$275.76M0.16-$190.45M-$3.08-1.59

Summary

Future Health ESG and Prenetics Global tied by winning 6 of the 12 factors compared between the two stocks.


Get Prenetics Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRE vs. The Competition

MetricPrenetics GlobalHolding Offices IndustryMedical SectorNASDAQ Exchange
Market Cap$44.88M$255.46M$4.97B$7.52B
Dividend YieldN/A8.47%2.87%3.87%
P/E Ratio-1.593.07192.6214.43
Price / Sales0.1615.083,024.8967.18
Price / CashN/A115.6394.4854.64
Price / Book0.1991.354.484.70
Net Income-$190.45M-$7.26M$112.73M$211.02M
7 Day Performance-0.81%0.21%5.35%3.25%
1 Month Performance4.47%-3.51%10.50%4.37%
1 Year Performance-70.64%-0.31%13.09%8.38%

Prenetics Global Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FHLT
Future Health ESG
0 of 5 stars
$10.63
-0.6%
N/AN/A$70.06MN/A0.002,021Short Interest ↑
ARYD
ARYA Sciences Acquisition Corp IV
0 of 5 stars
$11.22
-0.1%
N/A+9.7%$88.98MN/A0.003
CKPT
Checkpoint Therapeutics
3.8749 of 5 stars
$1.98
-1.5%
$22.60
+1,041.4%
-55.5%$46.59M$190,000.000.0024Gap Up
BYSI
BeyondSpring
0.2127 of 5 stars
$1.18
-11.3%
$1.25
+5.9%
-33.5%$45.93M$1.35M0.0073Short Interest ↓
AADI
Aadi Bioscience
2.9083 of 5 stars
$1.91
+0.5%
$24.67
+1,191.4%
-81.0%$46.85M$15.22M-0.8188Short Interest ↓
IMAC
IMAC
0 of 5 stars
$1.73
-5.5%
N/A+637.6%$45.82M$15.22M0.00106News Coverage
Gap Down
BNGO
Bionano Genomics
1.2602 of 5 stars
$1.21
-3.2%
$29.00
+2,296.7%
-90.2%$47.00M$27.80M-0.17388Upcoming Earnings
News Coverage
Gap Up
CTSO
Cytosorbents
2.3075 of 5 stars
$1.02
+1.0%
$2.50
+145.1%
-70.4%$45.33M$34.69M-1.92198Gap Down
TARA
Protara Therapeutics
3.229 of 5 stars
$3.99
-1.7%
$23.00
+476.4%
+23.8%$45.33MN/A-0.6525Short Interest ↓
News Coverage
Gap Up
High Trading Volume
FIXX
Homology Medicines
4.5838 of 5 stars
$0.82
+2.5%
$9.50
+1,053.1%
-41.0%$47.63M$3.21M-0.3692Gap Down

Related Companies and Tools

This page (NASDAQ:PRE) was last updated on 2/29/2024 by MarketBeat.com Staff